BELLEI, Elisa

	Titolo	Data di pubblicazione	Autore(i)
1	“VITAMIN E MODULATES BENZOYL PEROXIDE TOXICITY IN HUMAN KERATINOCYTES”	2002	MANFREDINI P; BELLEI E; BERGAMINI S; ROTA C; TOMASI A; ALBERTAZZI A; IANNONE A
2	Validation of prostate cancer biomarkers and inflammation: a proteomic study	2018	Ozben, T; Bergamini, S; Bellei, E; Cuoghi, A; Bianchi, G; Tomasi, A
3	Validation of prostate cancer biomarkers and inflammation: a proteomic study	2014	Bergamini, S; Bellei, E; Monari, E; Cuoghi, A; Reggiani Bonetti, L; Borelli, F; Sighinolfi M., C; Bianchi, G; Ozben, T; Tomasi, A
4	Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache	2015	Bellei, Elisa; Monari, Emanuela; Bergamini, Stefania; Cuoghi, Aurora; Tomasi, Aldo; Guerzoni, Simona; Ciccarese, Michela; Pini, Luigi Alberto
5	Urine proteomic analysis in patients with cronic headache and overuse of analgesic drugs: possible relation with renal damage	2011	Bellei E.; Bergamini S.; Cuoghi A.; Monari E.; Tomasi A.; Zappaterra M.; Bazzocchi A.; Guerzoni S.; Pini L.A.
6	Urine proteome in dogs affected by Leishmaniasis and Cushing's Syndrome	2013	Ferlizza, E; Buono, A; Fracassi, F; Dondi, F; Cuoghi, A; Bellei, E; Barrera, R; Borsetti, F; Carpenè, E; Isani, G
7	Urinary proteomics in biomarker discovery of kidney-related disorders: Diabetic nephropathy and drug-induced nephrotoxicity in chronic headache	2018	Bellei, Elisa; Monari, Emanuela; Bergamini, Stefania; Pini, Luigi Alberto; Tomasi, Aldo; Ozben, Tomris
8	Urinary protein profiling for biomarker discovery in diabetic nephropathy	2007	A. TOMASI; BELLEI E; MONARI E; ALBERTAZZI A; LUCCHI L
9	Superhighflux therapies for hemodialysis: ultrafiltrate proteomic profile and protein identification by on-chip elution.	2013	Monari, Emanuela; Cuoghi, Aurora; Caiazzo, Marialuisa; Bellei, Elisa; Bergamini, Stefania; Palladino, Giuseppe; Ozben, Tomris; Tomasi, Aldo.
10	Studio STEPS: Superior Therapies for hemodialysis. Approccio proteomico.	2012	M. Caiazzo; A. Cuoghi; E. Monari; E. Bellei; S. Bergamini; G. Palladino; A. Tomasi
11	Studio degli effetti della LDL aferesi in pazienti affetti da ipercolesterolemia familiare	2018	Merolle, L; Latorrata, A; Marraccini, C; Farioli, D; Scarano, L; Di Bartolomeo, E; Bergamini, S; Bellei, E; Monari, E; Fasano, T; Baricchi, R; Pertinhez, T. A.
12	Steps Study: Superhighflux therapies for hemodialysis. A proteomic approach.	2012	Caiazzo, Marialuisa; Monari, Emanuela; Cuoghi, Aurora; Bellei, Elisa; Bergamini, Stefania; Palladino, G.; Tomasi, Aldo
13	Serum protein changes in a rat model of chronic pain show a correlation between animal and humans	2017	Bellei, Elisa; Vilella, Antonietta; Monari, Emanuela; Bergamini, Stefania; Tomasi, Aldo; Cuoghi, Aurora; Guerzoni, Simona; Manca, Letizia; Zoli, Michele; Pini, Luigi Alberto
14	Serum changes of apolipoproteins in Medication Overuse Headache (MOH)	2018	Pellesi, Lanfranco; Bellei, Elisa; Baraldi, Carlo; Guerzoni, Simona; Monari, Emanuela; Pini, Luigi Alberto
15	“Role of NO in hypotension prone dialytic patients”	2003	A. IANNONE; E. BELLEI; S. BERGAMINI; C. ROTA; L. VANDELLI; A. ALBERTAZZI; A. TOMASI
16	Role of nitric oxide generating pathway in haemodialysis hypotension	2004	Bergamini, S; Rota, C; Bellei, E; Albertazzi, A; Vandelli, L; Tomasi, A; Iannone, A
17	Ricerca di markers diagnostici, prognostici e predittivi in carcinomi mammari attraverso analisi proteomica	2006	Pecorari, L; Silvestri, C; Candini, O; Rossi, E; Bellei, E; Bussolari, R; Iannone, A; Federico, M; Cortesi, L; Calabretta, B.
18	Ricerca di biomarkers nel tumore ovarico mediante analisi proteomica	2006	Rossi, E; Cortesi, L; Barchetti, A; Bellei, E; Monari, E; Tomasi, A; Iannone, A; Abrate, M; Federico, M.
19	Relationship of asymmetric dimethylarginine to haemodialysis hypotension	2004	S. Bergamini; L. Vandelli; E. Bellei; C. Rota; P. Manfredini; A. Tomasi; A. Albertazzi; A. Iannone
20	Redox regulation and antioxidant in shock	2004	Iannone, A; Bellei, E; Bergamini, S; Rota, C; Tomasi, A